Similar articles

• Mitochondria in neurodegenerative apoptosis: an opportunity for therapy?

  Tatton WG, Chalmers-Redman RM. Tatton WG, et al. Ann Neurol. 1998 Sep;44(3 Suppl 1):S134-41. doi: 10.1002/ana.410440720. Ann Neurol. 1998. PMID: 9749585 Review.
• Autophagy and apoptosis dysfunction in neurodegenerative disorders.

  Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ. Ghavami S, et al. Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Prog Neurobiol. 2014. PMID: 24211851 Review.
• Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!

  Cardoso SM, Correia SC, Carvalho C, Moreira PI. Cardoso SM, et al. Handb Exp Pharmacol. 2017;240:281-308. doi: 10.1007/164_2017_3. Handb Exp Pharmacol. 2017. PMID: 28251365 Review.
• Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases.

  Rego AC, Oliveira CR. Rego AC, et al. Neurochem Res. 2003 Oct;28(10):1563-74. doi: 10.1023/a:1025682611389. Neurochem Res. 2003. PMID: 14570402 Review.
• NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity.

  Stokman G, Kors L, Bakker PJ, Rampanelli E, Claessen N, Teske GJD, Butter L, van Andel H, van den Bergh Weerman MA, Larsen PWB, Dessing MC, Zuurbier CJ, Girardin SE, Florquin S, Leemans JC. Stokman G, et al. J Exp Med. 2017 Aug 7;214(8):2405-2420. doi: 10.1084/jem.20161031. Epub 2017 Jun 16. J Exp Med. 2017. PMID: 28626071 Free PMC article.